PIGA, Antonio Giulio
PIGA, Antonio Giulio
SCIENZE CLINICHE E BIOLOGICHE
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients
2013-01-01 D. Massano; S. De Francia; F. Longo; A. Sandri; F. Piccione; E. Pirro; S. Allegra; A. D’Avolio; A. Piga.
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008
2002-01-01 M. De Gobbi;A. Roetto;F. Daraio;F. Alberti;A. Piga;D. Girelli;C. Camaschella
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008
2002-01-01 M. De Gobbi;A. Roetto;F. Daraio;F. Alberti;A. Piga;D. Girelli;C. Camaschella
DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY IN THE ASSESSMENT OF SIGNIFICANT LIVER FIBROSIS IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTS
2010-01-01 T. Vinciguerra; F. Longo; P.L. Calvo; R. Romagnoli; M. Baldi; A. Brunati; D. Gonzalez de Requena Farre; G. Carbonaro; A. Pucci; A. Piga; M. Salizzoni; C. Barbera
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children
2016-01-01 Sarah Allegra, Jessica Cusato, Silvia De Francia, Arianna Arduino, Filomena Longo, Davide Massano, Antonio Piga, Antonio D'Avolio
Epigenetic Therapy for Friedreich’s Ataxia: A Phase I Clinical Trial
2014-01-01 Jacoby, D.; Rusche, J.; Iudicello, M.; De Mercanti, S.; Clerico, M; Gibbin, M.; Longo, F.; Miao, W.; Rai, M.; Piga, A.; Pandolfo, M.; Durelli, L.
Gender differences in five different drug pharmacokinetics
2019-01-01 S. Allegra, S. De Francia, A. E. Sprio, M. De Gobbi, A. Piga, A. De Nicolò, M. Antonucci, A. D’Avolio, S. Racca
HEPATO-SPLENIC SCINTIGRAPHY IN CHILDREN WITH BETA-THALASSEMIA (LA SCINTIGRAFIA EPATO-SPLENICA IN BAMBINI CON B-TALASSEMIA)
1985-01-01 Silvestro L; Piga A
Il bibliotecario formatore e la ricerca bibliografica guidata: uno studio randomizzato controllato
2010-01-01 Gardois, P; Calabrese, R; Colombi, N; Deplano, A; Lingua, C; Longo, F; Villanacci, Mc; Piga, A
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness
2014-01-01 Cusato, J; Allegra, S; Massano, D; De Francia, S; Piga, A; D'Avolio, A.
Rare Genetic Anemias Due to Defective Iron Recycling: Aceruloplasminemia and Type 4 Hemochromatosis
2003-01-01 C. Camaschella; S. Bosio; M. De Gobbi; G. Zecchina; F. Daraio; P. Porporato; F. Longo; A. Piga; A. Roetto
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes
2016-01-01 Sarah Allegra, Silvia De Francia, Jessica Cusato, Arianna Arduino, Elisa Pirro, Davide Massano, Filomena Longo, Antonio Piga, Antonio D'Avolio.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients | 2013 | D. Massano; S. De Francia; F. Longo; A. Sandri; F. Piccione; E. Pirro; S. Allegra; A. D’Avolio; A. Piga. | |
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 | 2002 | M. De Gobbi;A. Roetto;F. Daraio;F. Alberti;A. Piga;D. Girelli;C. Camaschella | |
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 | 2002 | M. De Gobbi;A. Roetto;F. Daraio;F. Alberti;A. Piga;D. Girelli;C. Camaschella | |
DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY IN THE ASSESSMENT OF SIGNIFICANT LIVER FIBROSIS IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTS | 2010 | T. Vinciguerra; F. Longo; P.L. Calvo; R. Romagnoli; M. Baldi; A. Brunati; D. Gonzalez de Requena Farre; G. Carbonaro; A. Pucci; A. Piga; M. Salizzoni; C. Barbera | |
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children | 2016 | Sarah Allegra, Jessica Cusato, Silvia De Francia, Arianna Arduino, Filomena Longo, Davide Massano, Antonio Piga, Antonio D'Avolio | |
Epigenetic Therapy for Friedreich’s Ataxia: A Phase I Clinical Trial | 2014 | Jacoby, D.; Rusche, J.; Iudicello, M.; De Mercanti, S.; Clerico, M; Gibbin, M.; Longo, F.; Miao, W.; Rai, M.; Piga, A.; Pandolfo, M.; Durelli, L. | |
Gender differences in five different drug pharmacokinetics | 2019 | S. Allegra, S. De Francia, A. E. Sprio, M. De Gobbi, A. Piga, A. De Nicolò, M. Antonucci, A. D’Avolio, S. Racca | |
HEPATO-SPLENIC SCINTIGRAPHY IN CHILDREN WITH BETA-THALASSEMIA (LA SCINTIGRAFIA EPATO-SPLENICA IN BAMBINI CON B-TALASSEMIA) | 1985 | Silvestro L; Piga A | |
Il bibliotecario formatore e la ricerca bibliografica guidata: uno studio randomizzato controllato | 2010 | Gardois, P; Calabrese, R; Colombi, N; Deplano, A; Lingua, C; Longo, F; Villanacci, Mc; Piga, A | |
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness | 2014 | Cusato, J; Allegra, S; Massano, D; De Francia, S; Piga, A; D'Avolio, A. | |
Rare Genetic Anemias Due to Defective Iron Recycling: Aceruloplasminemia and Type 4 Hemochromatosis | 2003 | C. Camaschella; S. Bosio; M. De Gobbi; G. Zecchina; F. Daraio; P. Porporato; F. Longo; A. Piga; A. Roetto | |
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes | 2016 | Sarah Allegra, Silvia De Francia, Jessica Cusato, Arianna Arduino, Elisa Pirro, Davide Massano, Filomena Longo, Antonio Piga, Antonio D'Avolio. |